133 related articles for article (PubMed ID: 78793)
1. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
Beck OA; Hochrein H
Dtsch Med Wochenschr; 1978 Aug; 103(32):1261-5. PubMed ID: 78793
[TBL] [Abstract][Full Text] [Related]
2. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
Beck OA
Med Klin; 1975 Jan; 70(3-2):95-101. PubMed ID: 48183
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of arrhythmias in infants and children using propafenone].
Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
[TBL] [Abstract][Full Text] [Related]
5. [Arrhythmias in the Wolff-Parkinson-White syndrome (author's transl)].
Lüderitz B; Steinbeck G
MMW Munch Med Wochenschr; 1976 Mar; 118(12):377-82. PubMed ID: 817167
[TBL] [Abstract][Full Text] [Related]
6. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
Weber H; Eigster G; Wesselhoeft H
Monatsschr Kinderheilkd; 1981 Jul; 129(7):410-3. PubMed ID: 6167855
[TBL] [Abstract][Full Text] [Related]
7. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of ventricular arrhythmias with propafenone].
Petri H; Kafka W; Rudolph W
Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
10. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
Seipel L; Breithardt G; Both A
Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
[TBL] [Abstract][Full Text] [Related]
12. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
Krikler DM
Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
[TBL] [Abstract][Full Text] [Related]
13. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cardiac arrhythmias in aged patients (author's transl)].
Hochrein H
Aktuelle Gerontol; 1980 Jan; 10(1):11-6. PubMed ID: 6158269
[TBL] [Abstract][Full Text] [Related]
15. [Effects of verapamil on sinusal function and on atrioventricular conduction along normal and abnormal pathways, in patients with pre-existing troubles of excitation conduction (author's transl)].
Disertori M; Molinis G; Lanzetta T; Antonini L; Furlanello F
G Ital Cardiol; 1976; 6(2):300-11. PubMed ID: 64371
[TBL] [Abstract][Full Text] [Related]
16. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Coumel P; Leclercq JF; Assayag P
Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
[TBL] [Abstract][Full Text] [Related]
17. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
18. [Medical management of tachycardias (author's transl)].
Petri H; Rudolph W
Herz; 1979 Aug; 4(4):344-58. PubMed ID: 93075
[TBL] [Abstract][Full Text] [Related]
19. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
Meyer-Estorf G; Keller K; Beck OA; Hochrein H
Z Kardiol; 1980 Jun; 69(6):417-20. PubMed ID: 6160684
[TBL] [Abstract][Full Text] [Related]
20. [Effect of oral propafenon on accessory pathways of atrioventricular conduction].
Lacroix H; Frank R; Tonet JL; Fontaine G; Wajman A; Squeir S; Grosgogeat Y
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):622-7. PubMed ID: 2860884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
